SCHEMBL10127352

SCHEMBL10127352

Cc1cccc2c1sc1c(-c3ccc(-c4nnc5c6ccccc6c6ccccc6n45)cc3)cccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.46
MAPT P10636 7/20 0.38
TP53 P04637 3/20 0.38
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
MAPK9 P45984 1/20 0.35
MAPK14 Q16539 1/20 0.35
RXFP1 Q9HBX9 2/20 0.34
PDE2A O00408 2/20 0.34
PDE10A Q9Y233 2/20 0.34
TYMS P04818 1/20 0.34
PDE6D O43924 1/20 0.34
PDE6A P16499 1/20 0.34
PDE6G P18545 1/20 0.34
PDE4A P27815 1/20 0.34
PDE6B P35913 1/20 0.34
PDE6C P51160 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10127378 0.92 POLB (0.51) POLBMAPTTP53KDM4EALDH1A1
SCHEMBL515618 0.87 POLB (0.46) POLBMAPTTP53KDM4EALDH1A1
SCHEMBL10127327 0.86 POLB (0.46) POLBMAPTTP53KDM4EALDH1A1
SCHEMBL10127427 0.83 ALOX5 (0.42) POLBMAPTTP53KDM4EALDH1A1
SCHEMBL10127353 0.83 POLB (0.46) POLBMAPTTP53KDM4EALDH1A1
SCHEMBL10127328 0.83 POLB (0.45) POLBMAPTTP53KDM4EALDH1A1
SCHEMBL10127428 0.81 ALOX5 (0.42) POLBMAPTTP53KDM4EALDH1A1
SCHEMBL10127329 0.80 POLB (0.47) POLBMAPTKDM4EALDH1A1HPGD
SCHEMBL10127426 0.79 ALOX5 (0.43) POLBMAPTTP53KDM4EALDH1A1
SCHEMBL10127383 0.79 POLB (0.51) POLBMAPTTP53KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
US-9034486-B2 Triazole derivative, heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD (JP) 2015-05-19 US disclosed
WO-2012017842-A1 TRIAZOLE DERIVATIVE, HETEROCYCLIC COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-09 WO disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025697-A1 Triazole Derivative, Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device HTR3D, KCNQ4, KCNQ3 POLB 3317/4885MAPT 1271/4885TP53 4442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.